1. Oxysophocarpine attenuates inflammatory osteolysis by modulating the NF-κb pathway and the reactive oxygen species-related Nrf2 signaling pathway.
- Author
-
Shi, Xiaofeng, Gao, Tian, Yu, Chaohong, Fu, Shaotian, Guo, Tingxian, Xu, Wei, Li, Xiaojun, Wang, Yitian, Zhang, Jingwei, Jia, Xinlin, and Mao, Yuanqing
- Subjects
- *
MACROPHAGE colony-stimulating factor , *BONE resorption , *REACTIVE oxygen species , *RESORPTION (Physiology) , *GENE expression - Abstract
Background and aim: Inflammatory diseases often result in bone loss due to persistent inflammation, which activates osteoclasts and increases bone resorption. Oxysophocarpine (OSC), a bioalkaloid extracted from the roots of Sophora japonica and other leguminous plants, has neuroprotective and anti-tumor properties. However, it is still uncertain whether OSC can effectively inhibit the differentiation of osteoclasts and bone resorption. Therefore, this study explored the potential role of OSC in osteoclast formation and inflammatory osteolysis and its underlying mechanisms. Experimental procedure: This study involved inducing primary mouse bone marrow macrophages (BMMs) into osteoclasts using macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL) and examined the effects of OSC on osteoclast (OC) differentiation, function, and intracellular reactive oxygen species (ROS) production. The impact of OSC on the expression of osteoclast-specific genes and inflammation-related factors was assessed using real-time quantitative PCR. Additionally, changes in oxidative stress-related factors, NF-κB, and MAPK signaling pathways were examined using western blotting. Finally, this study investigated the influence of OSC on a mouse cranial bone resorption model induced by titanium (Ti) particles in vivo. Results: OSC inhibited OC differentiation and resorption and reduces intracellular ROS levels. Moreover, OSC suppressed IL-1β, TNF-α, IL-6, and osteoclast-specific gene transcription while increasing Nrf2 and HO-1 protein expression. Furthermore, OSC inhibited the expression and autoregulation of the NFATc1 gene, ultimately leading to a reduction in Ti particle-induced bone resorption in mice. Conclusion: OSC could be regarded as an innovative medication for the treatment of osteoclast-associated inflammatory osteolytic diseases. [ABSTRACT FROM AUTHOR] more...
- Published
- 2024
- Full Text
- View/download PDF